All In MedTech

Device Trial Radar · NCT03767842

Volumetric Impedance to Guide Stroke Response

Last checked: Nov 21, 2026Latest source record: Dec 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

316

Planned (sponsor's estimate)

Start

Jul 18, 2018

Primary completion

Mar 31, 2019

Study completion Mar 31, 2019

Sponsor

Lead sponsor
Cerebrotech Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 7, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Assess the ability of the Visor System to detect hemispheric bioimpedance asymmetry

Conditions

  • Stroke, Acute

Interventions

  • Visor SystemDevice

    Subjects are monitored one time with the Visor System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hemispheric bioimpedance asymmetry sensitivity and specificityTime frame: At the time of device monitoring - day 0

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Buffalo Neurosurgery

    Buffalo, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.